Premium
This is an archive article published on September 13, 2024

Government should invest in R&D: Dr Soumya Swaminathan

Dr Soumya Swaminathan, principal advisor, National Tuberculosis Elimination Programme (NTEP), said that the government should lead in terms of investment, which will allow the private sector to follow suit.

Soumya Swaminathan, Tuberculosis, NTEP expert on Govts TB initiative, MS Swaminathan Research Foundation, Wheel Of Research launch, india, r&d policy, private sector, Indian express newsThe book launch organised by the Pune International Centre saw a discussion called 'The Silent Epidemic' with Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases, Indian Council of Medical Research, and Dr Vinay Kulkarni, coordinator Prayas Health Group, in participation.

Dr Soumya Swaminathan, principal advisor, National Tuberculosis Elimination Programme (NTEP), Government of India, and chairperson, MS Swaminathan Research Foundation, said that India requires a new research and development (R&D) policy in science.

Dr Swaminathan was speaking at the launch of the book “At The Wheel Of Research” authored by Anuradha Mascarenhas, senior editor at The Indian Express.

Dr Swaminathan added that the government should lead in terms of investment, which will allow the private sector to follow suit.

Story continues below this ad

“The Western model of research is unfortunately profit based. This research would happen only if there is a profit motive,” she said. The Indian model, she said, should be different and the government has to invest substantially in it. “The private sector would then follow suit,” she said.

The book launch organised by the Pune International Centre saw a discussion called ‘The Silent Epidemic’ with Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases, Indian Council of Medical Research, and Dr Vinay Kulkarni, coordinator Prayas Health Group, in participation.

Dr Swaminathan spoke about how tuberculosis was the silent pandemic. “Every day around 1,000 people die of tuberculosis in India. But unfortunately it does not get the attention it requires,” she said.

She added that the HIV pandemic came into news when the pressure groups in US started talking about it. Dr Gangakhedkar talked about the rise in antibiotic resistance, which is a cause of concern. “Unfortunately the body of antibiotics is really low and we should ensure resistance is not built,” he said. Indiscriminate usage of antibiotics and over the counter sale of drugs he said was responsible for this. Earlier Dr Raghunath Mashelkar, president, PIC, launched the book and spoke at the occasion.

Story continues below this ad

Dr Gangakhedkar and Dr Kulkarni said mpox would not spread too much in India. The present clade, Dr Gangakhedkar said, was not very infectious.


Click here to join Express Pune WhatsApp channel and get a curated list of our stories

Latest Comment
Post Comment
Read Comments
Advertisement
Loading Taboola...
Advertisement